USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Western Europe Point-of-Care Testing (POCT) Market
Western Europe Point-of-Care Testing (POCT) Market
RELEASE DATE
01-Jul-2016
01-Jul-2016
REGION
Europe
Europe
Research Code: MC01-01-00-00-00
SKU: HC02655-EU-MR_18715
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC02655-EU-MR_18715
Description
Point-of-care testing is an integral part of the IVD market that is rapidly evolving into a preferred testing mode in the EU region. POCT is a segment that presents growth opportunities for a cross-section of players, ranging from OEMs to data integrators to technology vendors. The stakeholders need to be abreast of the challenges posed by the industry as well as anticipate new avenues of growth to innovate to new business models and capitalize on the transformation that the market is undergoing. It is pertinent to understand key convergences that drive POCT sector growth and the technological building blocks that contribute to the future functionality of this market. This study will enable vendors in this space to look at future opportunities in POCT industry from an application-/therapeutic-area point of view and organic/inorganic means to monetize these opportunities.
RESEARCH: INFOGRAPHIC
This infographic presents a brief overview of the research, and highlights the key topics discussed in it.Click image to view it in full size
Table of Contents
Executive Summary—Market Snapshot
Western Europe Revenue Share—Forecast
Scope and Segmentation
Trends/Factors Impacting the POCT Market
8 Big Themes for the POCT Market of the Future
- Application Areas
- Consumer Preference
- Macroeconomic Factors
- Technology Advancement
Market Definition
Growth Opportunity by Customer Segment
Is POCT a Viable Option in Western Europe?
Cost Considerations of POCT Implementation in Europe
Pharmacoeconomic Metrics
- Blood Glucose Testing
- Infectious Disease
- Hb1Ac
- Pregnancy
- Cholesterol
- Cardiac Markers
- Rapid Coagulation
- Drugs of Abuse
- Urinalysis
- Blood Gas and Electrolytes
- Faecal Occult Test
- Haematology
Quantifiable Benefits of POCT in the EU Setting
- Home care*
- Primary Care (POL & Retail)
- Hospital Emergency Department
- Independent Labs
Drivers and Restraints
- Lab Tests
- Point-of-Care Testing
Market Share by Top Competitors
- Capital Costs
- Variable Costs
- Professional Costs
- Other Fixed Costs
Market Share Across Segments
Market Size and Growth Graph
Market Overview
- Market Drivers
- Market Restraints
Top 3 Strategic Segments in Western Europe
Niche Therapeutic Applications to Drive Future Growth
New Technology Advancements in POCT
Key Companies to Watch in Western Europe
POCT Reimbursement Landscape of the Future
Emergence of iPOCT
iPOCT Architecture
Future Model of POCT Ecosystem
POCT Value Chain Stakeholders
POCT Vendor Landscape
Competitive Environment
Competitive Analysis
Merger, Acquisition, and Partnership Assessment
Forecasting Methodology
Revenue Forecast
Revenue Forecast
Competitive Structure
Revenue Forecast
Competitive Structure
Revenue Forecast
Competitive Structure
Revenue Forecast
Competitive Structure
Revenue Forecast
Competitive Structure
Revenue Forecast
Competitive Structure
Revenue Forecast
Competitive Structure
Revenue Forecast
Competitive Structure
Revenue Forecast
Competitive Structure
Revenue Forecast
Competitive Structure
Revenue Forecast
Competitive Structure
Revenue Forecast
Competitive Structure
Western Europe POCT Segment Metrics Analysis
Revenue Share by Region
Revenue Forecast
Revenue Forecast
Revenue Forecast
Revenue Forecast
Revenue Forecast
Revenue Forecast
Revenue Forecast
The Last Word—3 Big Predictions
Legal Disclaimer
Market Engineering Methodology
List of Figures- 1. POCT Market: Turnaround Time of Selected Key Tests, US and Western Europe, 2014
- 2. Total POCT Market: Cost Analysis of Key Tests, Western Europe, 2014
- 3. POCT Market: Key Market Drivers and Restraints, Western Europe, 2016–2020
- 4. POCT Market: Competitive Structure, Western Europe, 2015
- 5. Total POCT Market: Notable Deals and Market Impact, Western Europe, 2015 and 2016
- 6. Infectious POCT Market: Competitive Structure, Western Europe, 2015
- 7. Cardiac POCT Market: Competitive Structure, Western Europe, 2015
- 8. Blood Glucose POCT Market : Competitive Structure, Western Europe, 2015
- 9. Hb1Ac POCT Market: Competitive Structure, Western Europe, 2015
- 10. Blood Gas and Electrolytes POCT Market: Competitive Structure, Western Europe, 2015
- 11. Rapid Coagulation POCT Market: Competitive Structure, Western Europe, 2015
- 12. Haematology POCT Market: Competitive Structure, Western Europe, 2015
- 13. Pregnancy POCT Market: Competitive Structure, Western Europe, 2015
- 14. Urinalysis POCT Market: Competitive Structure, Western Europe, 2015
- 15. Cholesterol POCT Market: Competitive Structure, Western Europe, 2015
- 16. Foecal Occult POCT Market: Competitive Structure, Western Europe, 2015
- 17. Drugs of Abuse POCT Market: Competitive Structure, Western Europe, 2015
List of Charts- 1. Total POCT Market: Percent Revenue Share by Segment, Western Europe, 2016 and 2020
- 2. Total POCT Market: Percent Sales Breakdown, Western Europe, 2015
- 3. Western European POCT Market: Barriers to POCT Adoption, 2014
- 4. POCT Market: Economic Drivers for POCT, Western Europe, 2015
- 5. Total POCT Market: Percent Revenue Breakdown, Western Europe, 2015
- 6. Total POCT Market: Percent Revenue Breakdown by Segment, Western Europe, 2015
- 7. Total POCT Market: Revenue and CAGR by Segment, Western Europe, 2015
- 8. Total POCT Market: Revenue Forecast, Western Europe, 2013–2020
- 9. Infectious POCT Market: Revenue Forecast, Western Europe, 2013–2020
- 10. Cardiac Testing POCT Market: Revenue Forecast, Western Europe, 2013–2020
- 11. Blood Glucose POCT Market: Revenue Forecast, Western Europe, 2013–2020
- 12. Hb1Ac POCT Market: Revenue Forecast, Western Europe, 2013–2020
- 13. Blood Gas and Electrolytes POCT Market: Revenue Forecast, Western Europe, 2013–2020
- 14. Rapid Coagulation POCT Market: Revenue Forecast, Western Europe, 2013–2020
- 15. Haematology POCT Market: Revenue Forecast, Western Europe, 2013–2020
- 16. Pregnancy POCT Market: Revenue Forecast, Western Europe, 2013–2020
- 17. Urinalysis POCT Market: Revenue Forecast, Western Europe, 2013–2020
- 18. Cholesterol POCT Market: Revenue Forecast, Western Europe, 2013–2020
- 19. Fecal Occult POCT Market: Revenue Forecast, Western Europe, 2013–2020
- 20. Drugs of Abuse POCT Market: Revenue Forecast, Western Europe, 2013–2020
- 21. POCT Market: Percent Revenue by Region, Western Europe, 2015
- 22. POCT Market: Revenue Forecast, UK, 2013–2020
- 23. POCT Market: Revenue Forecast, Germany, 2013–2020
- 24. POCT Market: Revenue Forecast, France, 2013–2020
- 25. POCT Market: Revenue Forecast, Italy, 2013–2020
- 26. POCT Market: Revenue Forecast, Spain, 2013–2020
- 27. POCT Market: Revenue Forecast, Benelux, 2013–2020
- 28. POCT Market: Revenue Forecast, Scandinavia, 2013–2020
Popular Topics
Point-of-care testing is an integral part of the IVD market that is rapidly evolving into a preferred testing mode in the EU region. POCT is a segment that presents growth opportunities for a cross-section of players, ranging from OEMs to data integrators to technology vendors. The stakeholders need to be abreast of the challenges posed by the industry as well as anticipate new avenues of growth to innovate to new business models and capitalize on the transformation that the market is undergoing. It is pertinent to understand key convergences that drive POCT sector growth and the technological building blocks that contribute to the future functionality of this market. This study will enable vendors in this space to look at future opportunities in POCT industry from an application-/therapeutic-area point of view and organic/inorganic means to monetize these opportunities.
| No Index | No |
|---|---|
| Podcast | No |
| Table of Contents | | Executive Summary~ || Executive Summary—Market Snapshot~ || Western Europe Revenue Share—Forecast~ || Scope and Segmentation~ || Trends/Factors Impacting the POCT Market~ || 8 Big Themes for the POCT Market of the Future~ ||| Application Areas~ ||| Consumer Preference~ ||| Macroeconomic Factors~ ||| Technology Advancement~ | Market Overview~ || Market Definition~ ||| Blood Glucose Testing~ ||| Infectious Disease~ ||| Hb1Ac~ ||| Pregnancy~ ||| Cholesterol~ ||| Cardiac Markers~ ||| Rapid Coagulation~ ||| Drugs of Abuse~ ||| Urinalysis~ ||| Blood Gas and Electrolytes~ ||| Faecal Occult Test~ ||| Haematology~ || Growth Opportunity by Customer Segment~ ||| Home care*~ ||| Primary Care (POL & Retail)~ ||| Hospital Emergency Department~ ||| Independent Labs~ || Is POCT a Viable Option in Western Europe?~ ||| Lab Tests~ |||| Pros~ |||| Cons~ ||| Point-of-Care Testing~ |||| Pros~ |||| Cons~ || Cost Considerations of POCT Implementation in Europe~ ||| Capital Costs~ ||| Variable Costs~ ||| Professional Costs~ ||| Other Fixed Costs~ || Pharmacoeconomic Metrics~ || Quantifiable Benefits of POCT in the EU Setting~ || Drivers and Restraints~ ||| Market Drivers~ |||| Promising applications in molecular diagnostics, antimicrobial resistance~ |||| Increased use in personalized medicine and companion diagnostics~ |||| Increased capacity in data connectivity, application to telemedicine~ |||| Miniaturisation of laboratory devices and microfluidics technology~ ||| Market Restraints~ |||| Test quality issues and increasing complaints; the need to prove consistency and effectiveness~ |||| Inconsistent reimbursement laws across the European region~ |||| Transition from fee-for-service to payment for outcomes~ || Market Share by Top Competitors~ ||| Danaher~ ||| Roche Diagnostics~ ||| Johnson & Johnson~ ||| Alere~ ||| Panasonic KKR Healthcare~ ||| Others*~ || Market Share Across Segments~ || Market Size and Growth Graph~ || Market Overview~ | Vision and Strategy—Growth Opportunities~ || Top 3 Strategic Segments in Western Europe~ ||| Sepsis~ ||| Antimicrobial Resistance~ ||| Oncology~ || Niche Therapeutic Applications to Drive Future Growth~ ||| Ocular Point-of-care~ ||| Traumatic Brain Injury~ ||| Rare Diseases~ ||| Neuropsychiatry Disorders~ ||| Molecular Diagnostics~ ||| Oncology~ || New Technology Advancements in POCT~ ||| Magnotech Biosensor~ ||| Breath Analyser~ ||| Multiplexed Lateral Flow Immunoassay~ ||| Integrated Cartridges~ ||| BioMEMS~ ||| Portable MDx~ || Key Companies to Watch in Western Europe~ ||| Atlas Genetics~ ||| RPS~ ||| Microvisk~ ||| Biodirection~ ||| Philips~ ||| Nicox~ || POCT Reimbursement Landscape of the Future~ ||| Cost Utility Analysis~ ||| Cost Effectiveness Analysis~ ||| Cost Benefit Analysis~ ||| Cost Minimisation Analysis~ || Emergence of iPOCT~ || iPOCT Architecture~ || Future Model of POCT Ecosystem~ | Competitive Playbook~ || POCT Value Chain Stakeholders~ || POCT Vendor Landscape~ || Competitive Environment~ || Competitive Analysis~ || Merger, Acquisition, and Partnership Assessment~ | Forecasts and Trends~ || Forecasting Methodology~ || Revenue Forecast~ | Infectious POCT Market Analysis~ || Revenue Forecast~ || Competitive Structure~ | Cardiac POCT Market Analysis~ || Revenue Forecast~ || Competitive Structure~ | Blood Glucose POCT Market Analysis~ || Revenue Forecast~ || Competitive Structure~ | Hb1Ac POCT Market Analysis~ || Revenue Forecast~ || Competitive Structure~ | Blood Gas and Electrolytes POCT Market Analysis~ || Revenue Forecast~ || Competitive Structure~ | Rapid Coagulation POCT Market Analysis~ || Revenue Forecast~ || Competitive Structure~ | Haematology POCT Market Analysis~ || Revenue Forecast~ || Competitive Structure~ | Pregnancy POCT Market Analysis~ || Revenue Forecast~ || Competitive Structure~ | Urinalysis POCT Market Analysis~ || Revenue Forecast~ || Competitive Structure~ | Cholesterol POCT Market Analysis~ || Revenue Forecast~ || Competitive Structure~ | Fecal Occult POCT Market Analysis~ || Revenue Forecast~ || Competitive Structure~ | Drugs of Abuse POCT Market Analysis~ || Revenue Forecast~ || Competitive Structure~ | POCT Segment Metrics Analysis~ || Western Europe POCT Segment Metrics Analysis~ | POCT—Regional Breakdown~ || Revenue Share by Region~ ||| Spain~ ||| UK~ ||| Benelux and Scandinavia~ ||| Germany~ ||| France~ ||| Italy~ | The United Kingdom Analysis~ || Revenue Forecast~ | Germany Analysis~ || Revenue Forecast~ | France Analysis~ || Revenue Forecast~ | Italy Analysis~ || Revenue Forecast~ | Spain Analysis~ || Revenue Forecast~ | Benelux Analysis~ || Revenue Forecast~ | Scandinavia Analysis~ || Revenue Forecast~ | The Last Word~ || The Last Word—3 Big Predictions~ || Legal Disclaimer~ | Appendix~ || Market Engineering Methodology~ |
| List of Charts and Figures | 1. POCT Market: Turnaround Time of Selected Key Tests, US and Western Europe, 2014~ 2. Total POCT Market: Cost Analysis of Key Tests, Western Europe, 2014~ 3. POCT Market: Key Market Drivers and Restraints, Western Europe, 2016–2020~ 4. POCT Market: Competitive Structure, Western Europe, 2015~ 5. Total POCT Market: Notable Deals and Market Impact, Western Europe, 2015 and 2016~ 6. Infectious POCT Market: Competitive Structure, Western Europe, 2015~ 7. Cardiac POCT Market: Competitive Structure, Western Europe, 2015~ 8. Blood Glucose POCT Market : Competitive Structure, Western Europe, 2015~ 9. Hb1Ac POCT Market: Competitive Structure, Western Europe, 2015~ 10. Blood Gas and Electrolytes POCT Market: Competitive Structure, Western Europe, 2015~ 11. Rapid Coagulation POCT Market: Competitive Structure, Western Europe, 2015~ 12. Haematology POCT Market: Competitive Structure, Western Europe, 2015~ 13. Pregnancy POCT Market: Competitive Structure, Western Europe, 2015~ 14. Urinalysis POCT Market: Competitive Structure, Western Europe, 2015~ 15. Cholesterol POCT Market: Competitive Structure, Western Europe, 2015~ 16. Foecal Occult POCT Market: Competitive Structure, Western Europe, 2015~ 17. Drugs of Abuse POCT Market: Competitive Structure, Western Europe, 2015~| 1. Total POCT Market: Percent Revenue Share by Segment, Western Europe, 2016 and 2020~ 2. Total POCT Market: Percent Sales Breakdown, Western Europe, 2015~ 3. Western European POCT Market: Barriers to POCT Adoption, 2014~ 4. POCT Market: Economic Drivers for POCT, Western Europe, 2015~ 5. Total POCT Market: Percent Revenue Breakdown, Western Europe, 2015~ 6. Total POCT Market: Percent Revenue Breakdown by Segment, Western Europe, 2015~ 7. Total POCT Market: Revenue and CAGR by Segment, Western Europe, 2015~ 8. Total POCT Market: Revenue Forecast, Western Europe, 2013–2020~ 9. Infectious POCT Market: Revenue Forecast, Western Europe, 2013–2020~ 10. Cardiac Testing POCT Market: Revenue Forecast, Western Europe, 2013–2020~ 11. Blood Glucose POCT Market: Revenue Forecast, Western Europe, 2013–2020~ 12. Hb1Ac POCT Market: Revenue Forecast, Western Europe, 2013–2020~ 13. Blood Gas and Electrolytes POCT Market: Revenue Forecast, Western Europe, 2013–2020~ 14. Rapid Coagulation POCT Market: Revenue Forecast, Western Europe, 2013–2020~ 15. Haematology POCT Market: Revenue Forecast, Western Europe, 2013–2020~ 16. Pregnancy POCT Market: Revenue Forecast, Western Europe, 2013–2020~ 17. Urinalysis POCT Market: Revenue Forecast, Western Europe, 2013–2020~ 18. Cholesterol POCT Market: Revenue Forecast, Western Europe, 2013–2020~ 19. Fecal Occult POCT Market: Revenue Forecast, Western Europe, 2013–2020~ 20. Drugs of Abuse POCT Market: Revenue Forecast, Western Europe, 2013–2020~ 21. POCT Market: Percent Revenue by Region, Western Europe, 2015~ 22. POCT Market: Revenue Forecast, UK, 2013–2020~ 23. POCT Market: Revenue Forecast, Germany, 2013–2020~ 24. POCT Market: Revenue Forecast, France, 2013–2020~ 25. POCT Market: Revenue Forecast, Italy, 2013–2020~ 26. POCT Market: Revenue Forecast, Spain, 2013–2020~ 27. POCT Market: Revenue Forecast, Benelux, 2013–2020~ 28. POCT Market: Revenue Forecast, Scandinavia, 2013–2020~ |
| Author | Sangeetha Prabakaran |
| Industries | Healthcare |
| WIP Number | MC01-01-00-00-00 |
| Keyword 1 | Point-of-Care Testing |
| Keyword 2 | Point-of-Care Diagnostics |
| Keyword 3 | Europe POCT |
| Is Prebook | No |
Similar Research
Check items to add to the cart or
